.](cia-0-0000Fig0){#f0-cia-0-0000}  ![Changes in International Prostate Symptom Score (IPSS), IPSS sub-scores and Overactive Bladder Symptom Score (OABSS) after treatment in Group A.\ **Notes:** \**P*\<0.00 changes from baseline; ^‡^*P*\<0.00 changes from 0 weeks.\ **Abbreviations:** dt, due to; NBC, nocturnal bladder capacity; NP, nocturnal polyuria; T, tamsulosin; T + D, tamsulosin + desmopressin; T + S, tamsulosin + solifenacin.](cia-0-0000Fig0){#f0-cia-0-0000}  ![Changes in 0-day voiding diary after treatment in Group A.\ **Notes:** \**P*\<0.00 changes from baseline; ^‡^*P*\<0.00 changes from 0 weeks.\ **Abbreviations:** dt, due to; NBC, nocturnal bladder capacity; NP, nocturnal polyuria; T, tamsulosin; T + D, tamsulosin + desmopressin; T + S, tamsulosin + solifenacin.](cia-0-0000Fig0){#f0-cia-0-0000}  ![Changes in International Prostate Symptom Score (IPSS), IPSS sub-scores